Alexion Pharmaceuticals reported $0 in Ordinary Share Capital for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acceleron Pharma XLRN:US $ 0.06M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Amgen AMGN:US $ 31989M 112M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Bristol Myers Squibb BMY:US $ 292M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
Esperion Therapeutics ESPR:US $ 27K 1000
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Insmed INSM:US $ 1.18M 32K
Moderna Inc MRNA:US 40.5K 40.5K
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Omeros OMER:US $ 625K 1000
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M